Hanns Möhler is Professor em. at the Swiss Federal Institute of Technology (ETH), Zurich and the University of Zurich, Switzerland. He has held a professorship in pharmacology in the Department of Chemistry and Applied Biosciences, ETH Zurich, as well as in the Medical Faculty of the University of Zurich, where he was director of the Institute of Pharmacology.

He was the first director of the Swiss National Center of Neuroscience Research and director of the Center of Experimental and Clinical Pharma Sciences at the University and the University Hospital of Zurich. Prior to his academic positions, Hanns Möhler was vice-director in the Research Department of Hoffmann-La Roche, Basle, Switzerland.

His discovery of the benzodiazepine receptor and his work on sleep disorders, the regulation of anxiety states, the gene therapy of epilepsy and the neuronal organization of memory was honored by numerous awards. In recent years, his work has been focused on cancer therapy. He is a member of the Swiss Academy of Medical Sciences and the European Academy of Sciences.